{
  "timestamp": "2025-12-02T00:58:13.423009",
  "pmcid": "PMC5561238",
  "source_file": "PMC5561238.json",
  "source_timestamp": "2025-12-02T00:57:38.805693",
  "prompts_used": {
    "var-fa": "improved_v2",
    "study-parameters": "study-parameters-v2",
    "var-pheno": "var-pheno-v5",
    "var-drug": "improved_v1",
    "summary": "basic"
  },
  "results": {
    "var-pheno": {
      "overall_score": 0.1466504037957783,
      "field_scores": {
        "Variant/Haplotypes": {
          "mean_score": 0.16279069767441862,
          "scores": [
            1.0,
            1.0,
            0.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Gene": {
          "mean_score": 0.18528694191644357,
          "scores": [
            1.0,
            1.0,
            0.967338502407074,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Drug(s)": {
          "mean_score": 0.18604651162790697,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Phenotype Category": {
          "mean_score": 0.18604651162790697,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Alleles": {
          "mean_score": 0.18540432425432427,
          "scores": [
            1.0,
            1.0,
            0.9723859429359436,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Is/Is Not associated": {
          "mean_score": 0.18604651162790697,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Direction of effect": {
          "mean_score": 0.06976744186046512,
          "scores": [
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Phenotype": {
          "mean_score": 0.17146152257919312,
          "scores": [
            0.9217570424079895,
            0.9205461740493774,
            0.9217570424079895,
            0.9217570424079895,
            0.9217570424079895,
            0.9217570424079895,
            0.9217570424079895,
            0.9217570424079895,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "When treated with/exposed to/when assayed with": {
          "mean_score": 0.18604651162790697,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Comparison Allele(s) or Genotype(s)": {
          "mean_score": 0.0,
          "scores": [
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        }
      },
      "total_samples": 43,
      "detailed_results": [
        {
          "sample_id": 0,
          "field_scores": {
            "Variant/Haplotypes": 1.0,
            "Gene": 1.0,
            "Drug(s)": 1.0,
            "Phenotype Category": 1.0,
            "Alleles": 1.0,
            "Is/Is Not associated": 1.0,
            "Direction of effect": 1.0,
            "Phenotype": 0.9217570424079895,
            "When treated with/exposed to/when assayed with": 1.0,
            "Comparison Allele(s) or Genotype(s)": 0.0
          },
          "field_values": {
            "Variant/Haplotypes": {
              "ground_truth": "HLA-B*15:01",
              "prediction": "HLA-B*15:01"
            },
            "Gene": {
              "ground_truth": "HLA-B",
              "prediction": "HLA-B"
            },
            "Drug(s)": {
              "ground_truth": "nevirapine",
              "prediction": "nevirapine"
            },
            "Phenotype Category": {
              "ground_truth": "Toxicity",
              "prediction": "toxicity"
            },
            "Alleles": {
              "ground_truth": "*15:01",
              "prediction": "*15:01"
            },
            "Is/Is Not associated": {
              "ground_truth": "Associated with",
              "prediction": "Associated with"
            },
            "Direction of effect": {
              "ground_truth": "decreased",
              "prediction": "decreased"
            },
            "Phenotype": {
              "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
              "prediction": "Side Effect:Cutaneous Nevirapine Hypersensitivity"
            },
            "When treated with/exposed to/when assayed with": {
              "ground_truth": "when treated with",
              "prediction": "when treated with"
            },
            "Comparison Allele(s) or Genotype(s)": {
              "ground_truth": null,
              "prediction": "non-carriers"
            }
          },
          "dependency_issues": []
        },
        {
          "sample_id": 1,
          "field_scores": {
            "Variant/Haplotypes": 1.0,
            "Gene": 1.0,
            "Drug(s)": 1.0,
            "Phenotype Category": 1.0,
            "Alleles": 1.0,
            "Is/Is Not associated": 1.0,
            "Direction of effect": 1.0,
            "Phenotype": 0.9205461740493774,
            "When treated with/exposed to/when assayed with": 1.0,
            "Comparison Allele(s) or Genotype(s)": 0.0
          },
          "field_values": {
            "Variant/Haplotypes": {
              "ground_truth": "HLA-B*52:01",
              "prediction": "HLA-B*52:01"
            },
            "Gene": {
              "ground_truth": "HLA-B",
              "prediction": "HLA-B"
            },
            "Drug(s)": {
              "ground_truth": "nevirapine",
              "prediction": "nevirapine"
            },
            "Phenotype Category": {
              "ground_truth": "Toxicity",
              "prediction": "toxicity"
            },
            "Alleles": {
              "ground_truth": "*52:01",
              "prediction": "*52:01"
            },
            "Is/Is Not associated": {
              "ground_truth": "Associated with",
              "prediction": "Associated with"
            },
            "Direction of effect": {
              "ground_truth": "decreased",
              "prediction": "decreased"
            },
            "Phenotype": {
              "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Severe Cutaneous Adverse Reactions, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms",
              "prediction": "Side Effect:Cutaneous Nevirapine Hypersensitivity"
            },
            "When treated with/exposed to/when assayed with": {
              "ground_truth": "when treated with",
              "prediction": "when treated with"
            },
            "Comparison Allele(s) or Genotype(s)": {
              "ground_truth": null,
              "prediction": "non-carriers"
            }
          },
          "dependency_issues": []
        },
        {
          "sample_id": 2,
          "field_scores": {
            "Variant/Haplotypes": 0.0,
            "Gene": 0.967338502407074,
            "Drug(s)": 1.0,
            "Phenotype Category": 1.0,
            "Alleles": 0.9723859429359436,
            "Is/Is Not associated": 1.0,
            "Direction of effect": 1.0,
            "Phenotype": 0.9217570424079895,
            "When treated with/exposed to/when assayed with": 1.0,
            "Comparison Allele(s) or Genotype(s)": 0.0
          },
          "field_values": {
            "Variant/Haplotypes": {
              "ground_truth": "HLA-B*15:01",
              "prediction": "HLA-DRB1*04:01"
            },
            "Gene": {
              "ground_truth": "HLA-B",
              "prediction": "HLA-DRB1"
            },
            "Drug(s)": {
              "ground_truth": "nevirapine",
              "prediction": "nevirapine"
            },
            "Phenotype Category": {
              "ground_truth": "Toxicity",
              "prediction": "toxicity"
            },
            "Alleles": {
              "ground_truth": "*15:01",
              "prediction": "*04:01"
            },
            "Is/Is Not associated": {
              "ground_truth": "Associated with",
              "prediction": "Associated with"
            },
            "Direction of effect": {
              "ground_truth": "decreased",
              "prediction": "decreased"
            },
            "Phenotype": {
              "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
              "prediction": "Side Effect:Cutaneous Nevirapine Hypersensitivity"
            },
            "When treated with/exposed to/when assayed with": {
              "ground_truth": "when treated with",
              "prediction": "when treated with"
            },
            "Comparison Allele(s) or Genotype(s)": {
              "ground_truth": null,
              "prediction": "non-carriers"
            }
          },
          "dependency_issues": []
        },
        {
          "sample_id": 3,
          "field_scores": {
            "Variant/Haplotypes": 1.0,
            "Gene": 1.0,
            "Drug(s)": 1.0,
            "Phenotype Category": 1.0,
            "Alleles": 1.0,
            "Is/Is Not associated": 1.0,
            "Direction of effect": 0.0,
            "Phenotype": 0.9217570424079895,
            "When treated with/exposed to/when assayed with": 1.0,
            "Comparison Allele(s) or Genotype(s)": 0.0
          },
          "field_values": {
            "Variant/Haplotypes": {
              "ground_truth": "HLA-C*05:01",
              "prediction": "HLA-C*05:01"
            },
            "Gene": {
              "ground_truth": "HLA-C",
              "prediction": "HLA-C"
            },
            "Drug(s)": {
              "ground_truth": "nevirapine",
              "prediction": "nevirapine"
            },
            "Phenotype Category": {
              "ground_truth": "Toxicity",
              "prediction": "toxicity"
            },
            "Alleles": {
              "ground_truth": "*05:01",
              "prediction": "*05:01"
            },
            "Is/Is Not associated": {
              "ground_truth": "Associated with",
              "prediction": "Associated with"
            },
            "Direction of effect": {
              "ground_truth": null,
              "prediction": "increased"
            },
            "Phenotype": {
              "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
              "prediction": "Side Effect:Cutaneous Nevirapine Hypersensitivity"
            },
            "When treated with/exposed to/when assayed with": {
              "ground_truth": "when treated with",
              "prediction": "when treated with"
            },
            "Comparison Allele(s) or Genotype(s)": {
              "ground_truth": null,
              "prediction": "non-carriers"
            }
          },
          "dependency_issues": []
        },
        {
          "sample_id": 4,
          "field_scores": {
            "Variant/Haplotypes": 1.0,
            "Gene": 1.0,
            "Drug(s)": 1.0,
            "Phenotype Category": 1.0,
            "Alleles": 1.0,
            "Is/Is Not associated": 1.0,
            "Direction of effect": 0.0,
            "Phenotype": 0.9217570424079895,
            "When treated with/exposed to/when assayed with": 1.0,
            "Comparison Allele(s) or Genotype(s)": 0.0
          },
          "field_values": {
            "Variant/Haplotypes": {
              "ground_truth": "HLA-B*35:05",
              "prediction": "HLA-B*35:05"
            },
            "Gene": {
              "ground_truth": "HLA-B",
              "prediction": "HLA-B"
            },
            "Drug(s)": {
              "ground_truth": "nevirapine",
              "prediction": "nevirapine"
            },
            "Phenotype Category": {
              "ground_truth": "Toxicity",
              "prediction": "toxicity"
            },
            "Alleles": {
              "ground_truth": "*35:05",
              "prediction": "*35:05"
            },
            "Is/Is Not associated": {
              "ground_truth": "Associated with",
              "prediction": "Associated with"
            },
            "Direction of effect": {
              "ground_truth": null,
              "prediction": "increased"
            },
            "Phenotype": {
              "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
              "prediction": "Side Effect:Cutaneous Nevirapine Hypersensitivity"
            },
            "When treated with/exposed to/when assayed with": {
              "ground_truth": "when treated with",
              "prediction": "when treated with"
            },
            "Comparison Allele(s) or Genotype(s)": {
              "ground_truth": null,
              "prediction": "non-carriers"
            }
          },
          "dependency_issues": []
        },
        {
          "sample_id": 5,
          "field_scores": {
            "Variant/Haplotypes": 1.0,
            "Gene": 1.0,
            "Drug(s)": 1.0,
            "Phenotype Category": 1.0,
            "Alleles": 1.0,
            "Is/Is Not associated": 1.0,
            "Direction of effect": 0.0,
            "Phenotype": 0.9217570424079895,
            "When treated with/exposed to/when assayed with": 1.0,
            "Comparison Allele(s) or Genotype(s)": 0.0
          },
          "field_values": {
            "Variant/Haplotypes": {
              "ground_truth": "HLA-DRB1*01:01",
              "prediction": "HLA-DRB1*01:01"
            },
            "Gene": {
              "ground_truth": "HLA-DRB1",
              "prediction": "HLA-DRB1"
            },
            "Drug(s)": {
              "ground_truth": "nevirapine",
              "prediction": "nevirapine"
            },
            "Phenotype Category": {
              "ground_truth": "Toxicity",
              "prediction": "toxicity"
            },
            "Alleles": {
              "ground_truth": "*01:01",
              "prediction": "*01:01"
            },
            "Is/Is Not associated": {
              "ground_truth": "Associated with",
              "prediction": "Associated with"
            },
            "Direction of effect": {
              "ground_truth": null,
              "prediction": "increased"
            },
            "Phenotype": {
              "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
              "prediction": "Side Effect:Cutaneous Nevirapine Hypersensitivity"
            },
            "When treated with/exposed to/when assayed with": {
              "ground_truth": "when treated with",
              "prediction": "when treated with"
            },
            "Comparison Allele(s) or Genotype(s)": {
              "ground_truth": null,
              "prediction": "non-carriers"
            }
          },
          "dependency_issues": []
        },
        {
          "sample_id": 6,
          "field_scores": {
            "Variant/Haplotypes": 1.0,
            "Gene": 1.0,
            "Drug(s)": 1.0,
            "Phenotype Category": 1.0,
            "Alleles": 1.0,
            "Is/Is Not associated": 1.0,
            "Direction of effect": 0.0,
            "Phenotype": 0.9217570424079895,
            "When treated with/exposed to/when assayed with": 1.0,
            "Comparison Allele(s) or Genotype(s)": 0.0
          },
          "field_values": {
            "Variant/Haplotypes": {
              "ground_truth": "HLA-C*04:01",
              "prediction": "HLA-C*04:01"
            },
            "Gene": {
              "ground_truth": "HLA-C",
              "prediction": "HLA-C"
            },
            "Drug(s)": {
              "ground_truth": "nevirapine",
              "prediction": "nevirapine"
            },
            "Phenotype Category": {
              "ground_truth": "Toxicity",
              "prediction": "toxicity"
            },
            "Alleles": {
              "ground_truth": "*04:01",
              "prediction": "*04:01"
            },
            "Is/Is Not associated": {
              "ground_truth": "Associated with",
              "prediction": "Associated with"
            },
            "Direction of effect": {
              "ground_truth": null,
              "prediction": "increased"
            },
            "Phenotype": {
              "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
              "prediction": "Side Effect:Cutaneous Nevirapine Hypersensitivity"
            },
            "When treated with/exposed to/when assayed with": {
              "ground_truth": "when treated with",
              "prediction": "when treated with"
            },
            "Comparison Allele(s) or Genotype(s)": {
              "ground_truth": null,
              "prediction": "non-carriers"
            }
          },
          "dependency_issues": []
        },
        {
          "sample_id": 7,
          "field_scores": {
            "Variant/Haplotypes": 1.0,
            "Gene": 1.0,
            "Drug(s)": 1.0,
            "Phenotype Category": 1.0,
            "Alleles": 1.0,
            "Is/Is Not associated": 1.0,
            "Direction of effect": 0.0,
            "Phenotype": 0.9217570424079895,
            "When treated with/exposed to/when assayed with": 1.0,
            "Comparison Allele(s) or Genotype(s)": 0.0
          },
          "field_values": {
            "Variant/Haplotypes": {
              "ground_truth": "HLA-C*18:01",
              "prediction": "HLA-C*18:01"
            },
            "Gene": {
              "ground_truth": "HLA-C",
              "prediction": "HLA-C"
            },
            "Drug(s)": {
              "ground_truth": "nevirapine",
              "prediction": "nevirapine"
            },
            "Phenotype Category": {
              "ground_truth": "Toxicity",
              "prediction": "toxicity"
            },
            "Alleles": {
              "ground_truth": "*18:01",
              "prediction": "*18:01"
            },
            "Is/Is Not associated": {
              "ground_truth": "Associated with",
              "prediction": "Associated with"
            },
            "Direction of effect": {
              "ground_truth": null,
              "prediction": "increased"
            },
            "Phenotype": {
              "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
              "prediction": "Side Effect:Cutaneous Nevirapine Hypersensitivity"
            },
            "When treated with/exposed to/when assayed with": {
              "ground_truth": "when treated with",
              "prediction": "when treated with"
            },
            "Comparison Allele(s) or Genotype(s)": {
              "ground_truth": null,
              "prediction": "non-carriers"
            }
          },
          "dependency_issues": []
        }
      ],
      "aligned_variants": [
        "PA165957192",
        "PA165955262",
        "PA165954745",
        "PA165951320",
        "PA165956366",
        "PA165957046",
        "PA165958003",
        "hla-drb1+nevirapine"
      ],
      "unmatched_ground_truth": [
        {
          "Variant Annotation ID": 1448926055,
          "Variant/Haplotypes": "HLA-B*67:01",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *67:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*67:01",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926055",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*67:01",
            "variant_id": "PA165956680",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926065,
          "Variant/Haplotypes": "HLA-B*78:01",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *78:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*78:01",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926065",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*78:01",
            "variant_id": "PA165956686",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448925992,
          "Variant/Haplotypes": "HLA-B*51:02",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *51:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*51:02",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448925992",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*51:02",
            "variant_id": "PA165956231",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926045,
          "Variant/Haplotypes": "HLA-B*56:06",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *56:06 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*56:06",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926045",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*56:06",
            "variant_id": "PA165956537",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926109,
          "Variant/Haplotypes": "HLA-B*39:01",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
          "Sentence": "HLA-B *39:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*39:01",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926109",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*39:01",
            "variant_id": "PA165955543",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448925913,
          "Variant/Haplotypes": "HLA-C*05:09",
          "Gene": "HLA-C",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Primary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-C alleles that share a common \"binding groove F pocket\" with HLA-C*04:01. The authors do not distinguish between the following HLA-C alleles, which is why the OR is the same: HLA-C*04:03/06/07, HLA-C*05:01/09, HLA-C*18:0.",
          "Sentence": "HLA-C *05:09 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*05:09",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448925913",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-C*05:09",
            "variant_id": "PA165957217",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926229,
          "Variant/Haplotypes": "HLA-B*15:32",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
          "Sentence": "HLA-B *15:32 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*15:32",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": "decreased",
          "Side effect/efficacy/other": "risk of",
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926229",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*15:32",
            "variant_id": "PA165954823",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448925982,
          "Variant/Haplotypes": "HLA-B*51:01",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *51:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*51:01",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448925982",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*51:01",
            "variant_id": "PA165956201",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926239,
          "Variant/Haplotypes": "HLA-B*15:35",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
          "Sentence": "HLA-B *15:35 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*15:35",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": "decreased",
          "Side effect/efficacy/other": "risk of",
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926239",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*15:35",
            "variant_id": "PA165954826",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926169,
          "Variant/Haplotypes": "HLA-B*15:12",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
          "Sentence": "HLA-B *15:12 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*15:12",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": "decreased",
          "Side effect/efficacy/other": "risk of",
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926169",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*15:12",
            "variant_id": "PA165954792",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448925972,
          "Variant/Haplotypes": "HLA-B*39:10",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *39:10 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*39:10",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448925972",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*39:10",
            "variant_id": "PA165955566",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926099,
          "Variant/Haplotypes": "HLA-B*38:02",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
          "Sentence": "HLA-B *38:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*38:02",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926099",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*38:02",
            "variant_id": "PA165955505",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926089,
          "Variant/Haplotypes": "HLA-B*38:01",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
          "Sentence": "HLA-B *38:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*38:01",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926089",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*38:01",
            "variant_id": "PA165955500",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926289,
          "Variant/Haplotypes": "HLA-DRB1*04:04",
          "Gene": "HLA-DRB1",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary risk of severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-DRB1*01:01/02/03, HLA-DRB1*04:04/05/08/10",
          "Sentence": "HLA-DRB1 *04:04 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*04:04",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926289",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-DRB1*04:04",
            "variant_id": "PA165951511",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926035,
          "Variant/Haplotypes": "HLA-B*56:01",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *56:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*56:01",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926035",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*56:01",
            "variant_id": "PA165956528",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926269,
          "Variant/Haplotypes": "HLA-DRB1*01:02",
          "Gene": "HLA-DRB1",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary risk of severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-DRB1*01:01/02/03, HLA-DRB1*04:04/05/08/10",
          "Sentence": "HLA-DRB1 *01:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*01:02",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926269",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-DRB1*01:02",
            "variant_id": "PA165951340",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926139,
          "Variant/Haplotypes": "HLA-B*39:09",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
          "Sentence": "HLA-B *39:09 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*39:09",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926139",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*39:09",
            "variant_id": "PA165955565",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926209,
          "Variant/Haplotypes": "HLA-B*15:27",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
          "Sentence": "HLA-B *15:27 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*15:27",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": "decreased",
          "Side effect/efficacy/other": "risk of",
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926209",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*15:27",
            "variant_id": "PA165954816",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448998275,
          "Variant/Haplotypes": "HLA-B*35:10",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-B*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *35:10 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Severe Cutaneous Adverse Reactions and Drug Reaction with Eosinophilia and Systemic Symptoms when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*35:10",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Severe Cutaneous Adverse Reactions, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms",
          "Multiple phenotypes And/or": "and",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448998275",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*35:10",
            "variant_id": "PA165955274",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448925883,
          "Variant/Haplotypes": "HLA-C*04:06",
          "Gene": "HLA-C",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Primary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-C alleles that share a common \"binding groove F pocket\" with HLA-C*04:01. The authors do not distinguish between the following HLA-C alleles, which is why the OR is the same: HLA-C*04:03/06/07, HLA-C*05:01/09, HLA-C*18:0.",
          "Sentence": "HLA-C *04:06 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*04:06",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448925883",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-C*04:06",
            "variant_id": "PA165957089",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926149,
          "Variant/Haplotypes": "HLA-B*57:01",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
          "Sentence": "HLA-B *57:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*57:01",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926149",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*57:01",
            "variant_id": "PA165987830",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448925893,
          "Variant/Haplotypes": "HLA-C*04:07",
          "Gene": "HLA-C",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Primary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-C alleles that share a common \"binding groove F pocket\" with HLA-C*04:01. The authors do not distinguish between the following HLA-C alleles, which is why the OR is the same: HLA-C*04:03/06/07, HLA-C*05:01/09, HLA-C*18:0.",
          "Sentence": "HLA-C *04:07 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Severe Cutaneous Adverse Reactions or Drug Reaction with Eosinophilia and Systemic Symptoms when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*04:07",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Severe Cutaneous Adverse Reactions, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448925893",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-C*04:07",
            "variant_id": "PA165957090",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926022,
          "Variant/Haplotypes": "HLA-B*55:02",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *55:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*55:02",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926022",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*55:02",
            "variant_id": "PA165956471",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926279,
          "Variant/Haplotypes": "HLA-DRB1*01:03",
          "Gene": "HLA-DRB1",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary risk of severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-DRB1*01:01/02/03, HLA-DRB1*04:04/05/08/10",
          "Sentence": "HLA-DRB1 *01:03 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*01:03",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926279",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-DRB1*01:03",
            "variant_id": "PA165951348",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926012,
          "Variant/Haplotypes": "HLA-B*55:01",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *55:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*55:01",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926012",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*55:01",
            "variant_id": "PA165956463",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926075,
          "Variant/Haplotypes": "HLA-B*13:02",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
          "Sentence": "HLA-B *13:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*13:02",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926075",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*13:02",
            "variant_id": "PA165954649",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926199,
          "Variant/Haplotypes": "HLA-B*15:25",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
          "Sentence": "HLA-B *15:25 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*15:25",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": "decreased",
          "Side effect/efficacy/other": "risk of",
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926199",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*15:25",
            "variant_id": "PA165954812",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926129,
          "Variant/Haplotypes": "HLA-B*39:06",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
          "Sentence": "HLA-B *39:06 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*39:06",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926129",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*39:06",
            "variant_id": "PA165955561",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448925873,
          "Variant/Haplotypes": "HLA-C*04:03",
          "Gene": "HLA-C",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Primary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-C alleles that share a common \"binding groove F pocket\" with HLA-C*04:01. The authors do not distinguish between the following HLA-C alleles, which is why the OR is the same: HLA-C*04:03/06/07, HLA-C*05:01/09, HLA-C*18:0.",
          "Sentence": "HLA-C *04:03 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*04:03",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448925873",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-C*04:03",
            "variant_id": "PA165957085",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926002,
          "Variant/Haplotypes": "HLA-B*54:01",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
          "Sentence": "HLA-B *54:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*54:01",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926002",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*54:01",
            "variant_id": "PA165956438",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926309,
          "Variant/Haplotypes": "HLA-DRB1*10:01",
          "Gene": "HLA-DRB1",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary risk of severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-DRB1*01:01/02/03, HLA-DRB1*04:04/05/08/10",
          "Sentence": "HLA-DRB1 *10:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms and Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*10:01",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "and",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926309",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-DRB1*10:01",
            "variant_id": "PA165951757",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926119,
          "Variant/Haplotypes": "HLA-B*39:05",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
          "Sentence": "HLA-B *39:05 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*39:05",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926119",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*39:05",
            "variant_id": "PA165955559",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1448926179,
          "Variant/Haplotypes": "HLA-B*15:24",
          "Gene": "HLA-B",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
          "Sentence": "HLA-B *15:24 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
          "Alleles": "*15:24",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": "decreased",
          "Side effect/efficacy/other": "risk of",
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "or",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": null,
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1448926179",
          "Variant/Haplotypes_normalized": {
            "normalized": "HLA-B*15:24",
            "variant_id": "PA165954811",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1449155757,
          "Variant/Haplotypes": "rs28399499",
          "Gene": "CYP2B6",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "The authors analyze rs28399499 T>C and rs3745274 G>A/T together as \"slow metabolizer\" genotypes.",
          "Sentence": "Allele C is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms and Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections as compared to allele T.",
          "Alleles": "C",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
          "Multiple phenotypes And/or": "and",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": "T",
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1449155757",
          "Variant/Haplotypes_normalized": {
            "normalized": "rs28399499",
            "variant_id": "PA166155478",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        },
        {
          "Variant Annotation ID": 1449155771,
          "Variant/Haplotypes": "rs3745274",
          "Gene": "CYP2B6",
          "Drug(s)": "nevirapine",
          "PMID": 28819312,
          "Phenotype Category": "Toxicity",
          "Significance": "not stated",
          "Notes": "The authors analyze rs28399499 T>C and rs3745274 G>A/T together as \"slow metabolizer\" genotypes.",
          "Sentence": "Allele T is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome and Drug Reaction with Eosinophilia and Systemic Symptoms when treated with nevirapine in people with HIV Infections as compared to allele G.",
          "Alleles": "T",
          "Specialty Population": null,
          "Metabolizer types": null,
          "isPlural": "Is",
          "Is/Is Not associated": "Associated with",
          "Direction of effect": null,
          "Side effect/efficacy/other": null,
          "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms",
          "Multiple phenotypes And/or": "and",
          "When treated with/exposed to/when assayed with": "when treated with",
          "Multiple drugs And/or": null,
          "Population types": "in people with",
          "Population Phenotypes or diseases": "Disease:HIV infectious disease",
          "Multiple phenotypes or diseases And/or": null,
          "Comparison Allele(s) or Genotype(s)": "G",
          "Comparison Metabolizer types": null,
          "PMID_norm": "28819312",
          "Variant Annotation ID_norm": "1449155771",
          "Variant/Haplotypes_normalized": {
            "normalized": "rs3745274",
            "variant_id": "PA166155409",
            "confidence": 1.0
          },
          "Drug(s)_normalized": {
            "normalized": "nevirapine",
            "drug_id": "PA450616",
            "confidence": 1.0
          }
        }
      ],
      "unmatched_predictions": []
    },
    "study-parameters": {
      "overall_score": 0.18830331652663473,
      "field_scores": {
        "Study Type": {
          "mean_score": 0.27906976744186046,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Study Cases": {
          "mean_score": 0.13953488372093023,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Study Controls": {
          "mean_score": 0.13953488372093023,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Characteristics": {
          "mean_score": 0.2408288176669631,
          "scores": [
            0.8719868063926697,
            0.8619092702865601,
            0.8563389182090759,
            0.8571669459342957,
            0.84229975938797,
            0.8723993301391602,
            0.8657593131065369,
            0.8593794703483582,
            0.8674772381782532,
            0.871196985244751,
            0.8681959509849548,
            0.8615291714668274,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Characteristics Type": {
          "mean_score": 0.0,
          "scores": [
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Frequency In Cases": {
          "mean_score": 0.27906976744186046,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Allele Of Frequency In Cases": {
          "mean_score": 0.27906976744186046,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Frequency In Controls": {
          "mean_score": 0.27906976744186046,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Allele Of Frequency In Controls": {
          "mean_score": 0.27906976744186046,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "P Value": {
          "mean_score": 0.09302325581395349,
          "scores": [
            1.0,
            1.0,
            1.0,
            0.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Ratio Stat Type": {
          "mean_score": 0.27906976744186046,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Ratio Stat": {
          "mean_score": 0.1930232558139535,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            0.9,
            0.8,
            0.9,
            0.9,
            0.8,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Confidence Interval Start": {
          "mean_score": 0.11162790697674418,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            0.8,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Confidence Interval Stop": {
          "mean_score": 0.09302325581395349,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        },
        "Biogeographical Groups": {
          "mean_score": 0.13953488372093023,
          "scores": [
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            1.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0,
            0.0
          ]
        }
      },
      "total_samples": 43,
      "detailed_results": [
        {
          "sample_id": 0,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 1.0,
            "Study Controls": 1.0,
            "Characteristics": 0.8719868063926697,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 1.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 1.0,
            "Confidence Interval Start": 1.0,
            "Confidence Interval Stop": 1.0,
            "Biogeographical Groups": 1.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448926231,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448926229,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": 151.0
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": 413.0
            },
            "Characteristics": {
              "ground_truth": "NCT00310843)",
              "prediction": "Carriage of protective HLA-B alleles (HLA-B*15:(01/12/24/25/27/32/35), -B*52:01) among HIV-1-infected adults initiating nevirapine-containing therapy (multivariate model)"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": ""
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 0.18,
              "prediction": 0.18
            },
            "Confidence Interval Start": {
              "ground_truth": 0.07,
              "prediction": 0.07
            },
            "Confidence Interval Stop": {
              "ground_truth": 0.46,
              "prediction": 0.46
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "Multiple Groups"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 1,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 1.0,
            "Study Controls": 1.0,
            "Characteristics": 0.8619092702865601,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 1.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 1.0,
            "Confidence Interval Start": 1.0,
            "Confidence Interval Stop": 1.0,
            "Biogeographical Groups": 1.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448925915,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448925913,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": 151.0
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": 413.0
            },
            "Characteristics": {
              "ground_truth": "NCT00310843)",
              "prediction": "Carriage of other risk F pocket HLA-C alleles (HLA-C*04:03/06/07, -C*05:01/09, -C*18:01) among HIV-1-infected adults initiating nevirapine-containing therapy (multivariate model)"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": ""
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 2.91,
              "prediction": 2.91
            },
            "Confidence Interval Start": {
              "ground_truth": 1.62,
              "prediction": 1.62
            },
            "Confidence Interval Stop": {
              "ground_truth": 5.23,
              "prediction": 5.23
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "Multiple Groups"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 2,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 1.0,
            "Study Controls": 1.0,
            "Characteristics": 0.8563389182090759,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 1.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 1.0,
            "Confidence Interval Start": 1.0,
            "Confidence Interval Stop": 1.0,
            "Biogeographical Groups": 1.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448926301,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448926299,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": 151.0
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": 413.0
            },
            "Characteristics": {
              "ground_truth": "NCT00310843",
              "prediction": "Carriage of risk HLA-DRB1 alleles (HLA-DRB1*01:(01/02/03), -DRB1*04:(04/05/08/10)) among HIV-1-infected adults initiating nevirapine-containing therapy (multivariate model)"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": ""
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 2.0,
              "prediction": 2.0
            },
            "Confidence Interval Start": {
              "ground_truth": 1.23,
              "prediction": 1.23
            },
            "Confidence Interval Stop": {
              "ground_truth": 3.24,
              "prediction": 3.24
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "Multiple Groups"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 3,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 1.0,
            "Study Controls": 1.0,
            "Characteristics": 0.8571669459342957,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 0.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 1.0,
            "Confidence Interval Start": 1.0,
            "Confidence Interval Stop": 1.0,
            "Biogeographical Groups": 1.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448925872,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448925862,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": 151.0
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": 413.0
            },
            "Characteristics": {
              "ground_truth": "NCT00310843",
              "prediction": "Carriage of HLA-C*04:01 among HIV-1-infected adults initiating nevirapine-containing therapy (multivariate logistic regression, adjusted for ancestry and other factors)"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": "= 1.0E-4",
              "prediction": ""
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 4.06,
              "prediction": 4.06
            },
            "Confidence Interval Start": {
              "ground_truth": 2.39,
              "prediction": 2.39
            },
            "Confidence Interval Stop": {
              "ground_truth": 6.88,
              "prediction": 6.88
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "Multiple Groups"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 4,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 1.0,
            "Study Controls": 1.0,
            "Characteristics": 0.84229975938797,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 1.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 0.9,
            "Confidence Interval Start": 0.8,
            "Confidence Interval Stop": 0.0,
            "Biogeographical Groups": 1.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448926291,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448926289,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": 151.0
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": 413.0
            },
            "Characteristics": {
              "ground_truth": "NCT00310843",
              "prediction": "Slow CYP2B6 metabolizer genotype (516G\u2192T and 983T\u2192C) among HIV-1-infected adults initiating nevirapine-containing therapy (multivariate model)"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": ""
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 2.0,
              "prediction": 2.07
            },
            "Confidence Interval Start": {
              "ground_truth": 1.23,
              "prediction": 1.12
            },
            "Confidence Interval Stop": {
              "ground_truth": 3.24,
              "prediction": 3.82
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "Multiple Groups"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 5,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 1.0,
            "Study Controls": 1.0,
            "Characteristics": 0.8723993301391602,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 0.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 0.8,
            "Confidence Interval Start": 0.0,
            "Confidence Interval Stop": 0.0,
            "Biogeographical Groups": 1.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448925905,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448925903,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": 151.0
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": 413.0
            },
            "Characteristics": {
              "ground_truth": "NCT00310843)",
              "prediction": "Carriage of HLA-C*04:01 vs non-carriage among HIV-1-infected adults initiating nevirapine-containing therapy; cases with severe cutaneous hypersensitivity reaction (grade 3/4)"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": "= 0.0001"
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 2.91,
              "prediction": 3.06
            },
            "Confidence Interval Start": {
              "ground_truth": 1.62,
              "prediction": null
            },
            "Confidence Interval Stop": {
              "ground_truth": 5.23,
              "prediction": null
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "Multiple Groups"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 6,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 0.0,
            "Study Controls": 0.0,
            "Characteristics": 0.8657593131065369,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 0.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 0.9,
            "Confidence Interval Start": 0.0,
            "Confidence Interval Stop": 0.0,
            "Biogeographical Groups": 0.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448925885,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448925883,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": null
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": null
            },
            "Characteristics": {
              "ground_truth": "NCT00310843)",
              "prediction": "Carriage of HLA-C*05:01 vs non-carriage among Caucasian (European/Hispanic) HIV-1-infected adults initiating nevirapine-containing therapy; cutaneous HSR"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": "= 0.002"
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 2.91,
              "prediction": 2.84
            },
            "Confidence Interval Start": {
              "ground_truth": 1.62,
              "prediction": null
            },
            "Confidence Interval Stop": {
              "ground_truth": 5.23,
              "prediction": null
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "European"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 7,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 0.0,
            "Study Controls": 0.0,
            "Characteristics": 0.8593794703483582,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 0.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 0.9,
            "Confidence Interval Start": 0.0,
            "Confidence Interval Stop": 0.0,
            "Biogeographical Groups": 0.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448926271,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448926269,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": null
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": null
            },
            "Characteristics": {
              "ground_truth": "NCT00310843",
              "prediction": "Carriage of HLA-C*04:01 vs non-carriage among Caucasian (European/Hispanic) HIV-1-infected adults initiating nevirapine-containing therapy; cutaneous HSR"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": "= 0.02"
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 2.0,
              "prediction": 2.08
            },
            "Confidence Interval Start": {
              "ground_truth": 1.23,
              "prediction": null
            },
            "Confidence Interval Stop": {
              "ground_truth": 3.24,
              "prediction": null
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "European"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 8,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 0.0,
            "Study Controls": 0.0,
            "Characteristics": 0.8674772381782532,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 0.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 0.8,
            "Confidence Interval Start": 0.0,
            "Confidence Interval Stop": 0.0,
            "Biogeographical Groups": 0.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448925895,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448925893,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": null
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": null
            },
            "Characteristics": {
              "ground_truth": "NCT00310843)",
              "prediction": "Carriage of HLA-C*18:01 vs non-carriage among African-ancestry HIV-1-infected adults initiating nevirapine-containing therapy; cutaneous HSR"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": "= 0.2"
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 2.91,
              "prediction": 2.67
            },
            "Confidence Interval Start": {
              "ground_truth": 1.62,
              "prediction": null
            },
            "Confidence Interval Stop": {
              "ground_truth": 5.23,
              "prediction": null
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "African America/Afro-Caribbean"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 9,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 0.0,
            "Study Controls": 0.0,
            "Characteristics": 0.871196985244751,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 0.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 0.0,
            "Confidence Interval Start": 0.0,
            "Confidence Interval Stop": 0.0,
            "Biogeographical Groups": 0.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448926057,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448926055,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": null
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": null
            },
            "Characteristics": {
              "ground_truth": "NCT00310843)",
              "prediction": "Carriage of HLA-C*04:01 vs non-carriage among African American HIV-1-infected adults initiating nevirapine-containing therapy; cutaneous HSR"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": "= 0.04"
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 2.32,
              "prediction": 3.84
            },
            "Confidence Interval Start": {
              "ground_truth": 1.42,
              "prediction": null
            },
            "Confidence Interval Stop": {
              "ground_truth": 3.79,
              "prediction": null
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "African America/Afro-Caribbean"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 10,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 0.0,
            "Study Controls": 0.0,
            "Characteristics": 0.8681959509849548,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 0.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 0.0,
            "Confidence Interval Start": 0.0,
            "Confidence Interval Stop": 0.0,
            "Biogeographical Groups": 0.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448926067,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448926065,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": null
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": null
            },
            "Characteristics": {
              "ground_truth": "NCT00310843)",
              "prediction": "Carriage of HLA-C*18:01 compared to non-HLA-C*04:01/*-C*18:01 carriers among African-ancestry HIV-1-infected adults initiating nevirapine-containing therapy; cutaneous HSR"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": "= 0.06"
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 2.32,
              "prediction": 4.71
            },
            "Confidence Interval Start": {
              "ground_truth": 1.42,
              "prediction": null
            },
            "Confidence Interval Stop": {
              "ground_truth": 3.79,
              "prediction": null
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "African America/Afro-Caribbean"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        },
        {
          "sample_id": 11,
          "field_scores": {
            "Study Parameters ID": 0.0,
            "Variant Annotation ID": 0.0,
            "Study Type": 1.0,
            "Study Cases": 0.0,
            "Study Controls": 0.0,
            "Characteristics": 0.8615291714668274,
            "Characteristics Type": 0.0,
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": 1.0,
            "Frequency In Controls": 1.0,
            "Allele Of Frequency In Controls": 1.0,
            "P Value": 0.0,
            "Ratio Stat Type": 1.0,
            "Ratio Stat": 0.0,
            "Confidence Interval Start": 0.0,
            "Confidence Interval Stop": 0.0,
            "Biogeographical Groups": 0.0
          },
          "field_values": {
            "Study Parameters ID": {
              "ground_truth": 1448925994,
              "prediction": null
            },
            "Variant Annotation ID": {
              "ground_truth": 1448925992,
              "prediction": null
            },
            "Study Type": {
              "ground_truth": "case/control",
              "prediction": "case/control"
            },
            "Study Cases": {
              "ground_truth": 151.0,
              "prediction": null
            },
            "Study Controls": {
              "ground_truth": 413.0,
              "prediction": null
            },
            "Characteristics": {
              "ground_truth": "NCT00310843)",
              "prediction": "Carriage of HLA-C*04:01 vs non-carriage among Asian (East Asian) HIV-1-infected adults initiating nevirapine-containing therapy; cutaneous HSR"
            },
            "Characteristics Type": {
              "ground_truth": "Study Cohort",
              "prediction": "drug"
            },
            "Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Cases": {
              "ground_truth": null,
              "prediction": null
            },
            "Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "Allele Of Frequency In Controls": {
              "ground_truth": null,
              "prediction": null
            },
            "P Value": {
              "ground_truth": null,
              "prediction": "= 0.0001"
            },
            "Ratio Stat Type": {
              "ground_truth": "OR",
              "prediction": "OR"
            },
            "Ratio Stat": {
              "ground_truth": 2.32,
              "prediction": 5.49
            },
            "Confidence Interval Start": {
              "ground_truth": 1.42,
              "prediction": null
            },
            "Confidence Interval Stop": {
              "ground_truth": 3.79,
              "prediction": null
            },
            "Biogeographical Groups": {
              "ground_truth": "Multiple groups",
              "prediction": "East Asian"
            }
          },
          "dependency_issues": [],
          "penalty_info": {
            "total_penalty": 0.0,
            "penalized_fields": {},
            "issues_by_field": {}
          }
        }
      ],
      "aligned_variants": [
        "case/control:NCT00310843)",
        "case/control:NCT00310843)",
        "case/control:NCT00310843",
        "case/control:NCT00310843",
        "case/control:NCT00310843",
        "case/control:NCT00310843)",
        "case/control:NCT00310843)",
        "case/control:NCT00310843",
        "case/control:NCT00310843)",
        "case/control:NCT00310843)",
        "case/control:NCT00310843)",
        "case/control:NCT00310843)"
      ],
      "unmatched_ground_truth": [
        {
          "Study Parameters ID": 1448926047,
          "Variant Annotation ID": 1448926045,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.32,
          "Confidence Interval Start": 1.42,
          "Confidence Interval Stop": 3.79,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926045"
        },
        {
          "Study Parameters ID": 1448926111,
          "Variant Annotation ID": 1448926109,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 1.76,
          "Confidence Interval Start": 1.02,
          "Confidence Interval Stop": 3.02,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926109"
        },
        {
          "Study Parameters ID": 1448925984,
          "Variant Annotation ID": 1448925982,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.32,
          "Confidence Interval Start": 1.42,
          "Confidence Interval Stop": 3.79,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448925982"
        },
        {
          "Study Parameters ID": 1448926241,
          "Variant Annotation ID": 1448926239,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 0.18,
          "Confidence Interval Start": 0.07,
          "Confidence Interval Stop": 0.46,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926239"
        },
        {
          "Study Parameters ID": 1448926171,
          "Variant Annotation ID": 1448926169,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 0.18,
          "Confidence Interval Start": 0.07,
          "Confidence Interval Stop": 0.46,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926169"
        },
        {
          "Study Parameters ID": 1448925974,
          "Variant Annotation ID": 1448925972,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.32,
          "Confidence Interval Start": 1.42,
          "Confidence Interval Stop": 3.79,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448925972"
        },
        {
          "Study Parameters ID": 1448926101,
          "Variant Annotation ID": 1448926099,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 1.76,
          "Confidence Interval Start": 1.02,
          "Confidence Interval Stop": 3.02,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926099"
        },
        {
          "Study Parameters ID": 1448926091,
          "Variant Annotation ID": 1448926089,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 1.76,
          "Confidence Interval Start": 1.02,
          "Confidence Interval Stop": 3.02,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926089"
        },
        {
          "Study Parameters ID": 1448926037,
          "Variant Annotation ID": 1448926035,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.32,
          "Confidence Interval Start": 1.42,
          "Confidence Interval Stop": 3.79,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926035"
        },
        {
          "Study Parameters ID": 1448925960,
          "Variant Annotation ID": 1448925958,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.32,
          "Confidence Interval Start": 1.42,
          "Confidence Interval Stop": 3.79,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448925958"
        },
        {
          "Study Parameters ID": 1448926141,
          "Variant Annotation ID": 1448926139,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 1.76,
          "Confidence Interval Start": 1.02,
          "Confidence Interval Stop": 3.02,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926139"
        },
        {
          "Study Parameters ID": 1448926161,
          "Variant Annotation ID": 1448926159,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 0.18,
          "Confidence Interval Start": 0.07,
          "Confidence Interval Stop": 0.46,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926159"
        },
        {
          "Study Parameters ID": 1448926211,
          "Variant Annotation ID": 1448926209,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 0.18,
          "Confidence Interval Start": 0.07,
          "Confidence Interval Stop": 0.46,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926209"
        },
        {
          "Study Parameters ID": 1448998277,
          "Variant Annotation ID": 1448998275,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.32,
          "Confidence Interval Start": 1.42,
          "Confidence Interval Stop": 3.79,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448998275"
        },
        {
          "Study Parameters ID": 1448926151,
          "Variant Annotation ID": 1448926149,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 1.76,
          "Confidence Interval Start": 1.02,
          "Confidence Interval Stop": 3.02,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926149"
        },
        {
          "Study Parameters ID": 1448926024,
          "Variant Annotation ID": 1448926022,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.32,
          "Confidence Interval Start": 1.42,
          "Confidence Interval Stop": 3.79,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926022"
        },
        {
          "Study Parameters ID": 1448926281,
          "Variant Annotation ID": 1448926279,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.0,
          "Confidence Interval Start": 1.23,
          "Confidence Interval Stop": 3.24,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926279"
        },
        {
          "Study Parameters ID": 1448926014,
          "Variant Annotation ID": 1448926012,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.32,
          "Confidence Interval Start": 1.42,
          "Confidence Interval Stop": 3.79,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926012"
        },
        {
          "Study Parameters ID": 1448926077,
          "Variant Annotation ID": 1448926075,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 1.76,
          "Confidence Interval Start": 1.02,
          "Confidence Interval Stop": 3.02,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926075"
        },
        {
          "Study Parameters ID": 1448926201,
          "Variant Annotation ID": 1448926199,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 0.18,
          "Confidence Interval Start": 0.07,
          "Confidence Interval Stop": 0.46,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926199"
        },
        {
          "Study Parameters ID": 1448926131,
          "Variant Annotation ID": 1448926129,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 1.76,
          "Confidence Interval Start": 1.02,
          "Confidence Interval Stop": 3.02,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926129"
        },
        {
          "Study Parameters ID": 1448925875,
          "Variant Annotation ID": 1448925873,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.91,
          "Confidence Interval Start": 1.62,
          "Confidence Interval Stop": 5.23,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448925873"
        },
        {
          "Study Parameters ID": 1448926004,
          "Variant Annotation ID": 1448926002,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.32,
          "Confidence Interval Start": 1.42,
          "Confidence Interval Stop": 3.79,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926002"
        },
        {
          "Study Parameters ID": 1448926261,
          "Variant Annotation ID": 1448926259,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.0,
          "Confidence Interval Start": 1.23,
          "Confidence Interval Stop": 3.24,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926259"
        },
        {
          "Study Parameters ID": 1448926251,
          "Variant Annotation ID": 1448926249,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 0.18,
          "Confidence Interval Start": 0.07,
          "Confidence Interval Stop": 0.46,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926249"
        },
        {
          "Study Parameters ID": 1448926311,
          "Variant Annotation ID": 1448926309,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.0,
          "Confidence Interval Start": 1.23,
          "Confidence Interval Stop": 3.24,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926309"
        },
        {
          "Study Parameters ID": 1448926121,
          "Variant Annotation ID": 1448926119,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 1.76,
          "Confidence Interval Start": 1.02,
          "Confidence Interval Stop": 3.02,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926119"
        },
        {
          "Study Parameters ID": 1448925925,
          "Variant Annotation ID": 1448925923,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.91,
          "Confidence Interval Start": 1.62,
          "Confidence Interval Stop": 5.23,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448925923"
        },
        {
          "Study Parameters ID": 1448926181,
          "Variant Annotation ID": 1448926179,
          "Study Type": "case/control",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "NCT00310843)",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 0.18,
          "Confidence Interval Start": 0.07,
          "Confidence Interval Stop": 0.46,
          "Biogeographical Groups": "Multiple groups",
          "Variant Annotation ID_norm": "1448926179"
        },
        {
          "Study Parameters ID": 1449155766,
          "Variant Annotation ID": 1449155757,
          "Study Type": "case/control, clinical trial",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "Study Cohort: NCT00310843",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.07,
          "Confidence Interval Start": 1.12,
          "Confidence Interval Stop": 3.82,
          "Biogeographical Groups": "Unknown",
          "Variant Annotation ID_norm": "1449155757"
        },
        {
          "Study Parameters ID": 1449155773,
          "Variant Annotation ID": 1449155771,
          "Study Type": "case/control, clinical trial",
          "Study Cases": 151.0,
          "Study Controls": 413.0,
          "Characteristics": "Study Cohort: NCT00310843",
          "Characteristics Type": "Study Cohort",
          "Frequency In Cases": null,
          "Allele Of Frequency In Cases": null,
          "Frequency In Controls": null,
          "Allele Of Frequency In Controls": null,
          "P Value": null,
          "Ratio Stat Type": "OR",
          "Ratio Stat": 2.07,
          "Confidence Interval Start": 1.12,
          "Confidence Interval Stop": 3.82,
          "Biogeographical Groups": "Unknown",
          "Variant Annotation ID_norm": "1449155771"
        }
      ],
      "unmatched_predictions": []
    }
  },
  "metadata": {
    "ground_truth_file": "persistent_data/benchmark_annotations.json",
    "total_tasks": 2,
    "average_score": 0.16692879552001103,
    "tasks_with_errors": 0
  }
}